| [1] |
Chen Y, Dong E, Grayson DR. Analysis of the GAD1 promoter: trans-acting factors and DNA methylation converge on the 5' untranslated region[J]. Neuropharmacology, 2011, 60(7/8): 1075-87. https://www.researchgate.net/profile/Dennis_Grayson/publication/46425881_Chen_Y_Dong_E_Grayson_DR_Analysis_of_the_GAD1_promoter_trans-acting_factors_and_DNA_methylation_converge_on_the_5%27_untranslated_region_Neuropharmacology_60_1075-1087/links/53d937f10cf2e38c6331f422.pdf?origin=publication_detail
|
| [2] |
Zhang TY, Hellstrom IC, Bagot RC, et al. Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus[J]. J Neurosci, 2010, 30(39): 13130-7. doi: 10.1523/JNEUROSCI.1039-10.2010
|
| [3] |
Levenson JM. DNA (cytosine-5) methyltransferase inhibitors: a potential therapeutic agent for schizophrenia[J]. Mol Pharmacol, 2007, 71(3): 635-7. http://molpharm.aspetjournals.org/content/71/3/635
|
| [4] |
Veldic M, Caruncho HJ, Liu WS, et al. DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains[J]. Proc Natl Acad Sci USA, 2004, 101(1): 348-53. doi: 10.1073/pnas.2637013100
|
| [5] |
Veldic M, Guidotti A, Maloku E, et al. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1[J]. Proc Natl Acad Sci USA, 2005, 102(6): 2152-7. doi: 10.1073/pnas.0409665102
|
| [6] |
Veldic M, Kadriu B, Maloku E, et al. Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder[J]. Schizophr Res, 2007, 91(1/3): 51-61. http://www.academia.edu/8906239/Epigenetic_mechanisms_expressed_in_basal_ganglia_GABAergic_neurons_differentiate_schizophrenia_from_bipolar_disorder
|
| [7] |
Tremolizzo L, Carboni G, Ruzicka WB, et al. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability[J]. Proc Natl Acad Sci USA, 2002, 99(26): 17095-100. doi: 10.1073/pnas.262658999
|
| [8] |
Dong E, Agis-Balboa RC, Simonini MV, et al. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia[J]. Proc Natl Acad Sci U S A, 2005, 102(35): 12578-83. doi: 10.1073/pnas.0505394102
|
| [9] |
Nusser Z, Sieghart W, Somogyi P. Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells[J]. J Neurosci, 1998, 18(5): 1693-703. https://www.researchgate.net/publication/13765867_Segregation_of_Different_GABAA_Receptors_to_Synaptic_and_Extrasynaptic_Membranes_of_Cerebellar_Granule_Cells
|
| [10] |
Petryshen TL, Middleton FA, Tahl AR, et al. Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia[J]. Mol Psychiatry, 2005, 10(12): 1074-88, 1057. doi: 10.1038/sj.mp.4001739
|
| [11] |
Zhao C, Xu Z, Chen J, et al. Two isoforms of GABA(A) receptor beta2 subunit with different electrophysiological properties: Differential expression and genotypical correlations in schizophrenia[J]. Mol Psychiatry, 2006, 11(12): 1092-105. doi: 10.1038/sj.mp.4001899
|
| [12] |
Lo WS, Lau CF, Xuan Z, et al. Association of SNPs and haplotypes in GABAA receptor beta2 gene with schizophrenia[J]. Mol Psychiatry, 2004, 9(6): 603-8. doi: 10.1038/sj.mp.4001461
|
| [13] |
Liu J, Shi Y, Tang W, et al. Positive association of the human GABA-A-receptor beta 2 subunit gene haplotype with schizophrenia in the Chinese Han population[J]. Biochem Biophys Res Commun, 2005, 334(3): 817-23. doi: 10.1016/j.bbrc.2005.06.167
|
| [14] |
Petryshen TL, Middleton FA, Tahl AR, et al. Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia[J]. Mol Psychiatry, 2005, 10(12): 1074-88, 1057. doi: 10.1038/sj.mp.4001739
|
| [15] |
Lo WS, Harano M, Gawlik M, et al. GABRB2 association with schizophrenia: commonalities and differences between ethnic groups and clinical subtypes[J]. Biol Psychiatry, 2007, 61(5): 653-60. doi: 10.1016/j.biopsych.2006.05.003
|
| [16] |
Ng SK, Lo WS, Pun FW, et al. A recombination hotspot in a schizophrenia-associated region of GABRB2[J]. PLoS One, 2010, 5(3): e9547. doi: 10.1371/journal.pone.0009547
|
| [17] |
Lo WS, Xu Z, Yu Z, et al. Positive selection within the Schizophrenia-associated GABA(A) receptor beta(2) gene[J]. PLoS One, 2007, 2(5): e462. doi: 10.1371/journal.pone.0000462
|
| [18] |
Pun FW, Zhao C, Lo WS, et al. Imprinting in the schizophrenia candidate gene GABRB2 encoding GABA(A) receptor β(2) subunit[J]. Mol Psychiatry, 2011, 16(5): 557-68. doi: 10.1038/mp.2010.47
|
| [19] |
Lott SA, Burghardt PR, Burghardt KJ, et al. The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia[J]. Pharmacogenomics J, 2013, 13(3): 264-71. doi: 10.1038/tpj.2012.6
|
| [20] |
Roffman JL, Weiss AP, Deckersbach T, et al. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia[J]. Am J Med Genet B Neuropsychiatr Genet, 2008, 147B(6): 990-5. doi: 10.1002/ajmg.b.30684
|
| [21] |
Abdolmaleky HM, Cheng KH, Faraone SV, et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder[J]. Hum Mol Genet, 2006, 15(21): 3132-45. doi: 10.1093/hmg/ddl253
|
| [22] |
Inayama Y, Yoneda H, Sakai T, et al. Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia[J]. Am J Med Genet, 1996, 67(1): 103-5. doi: 10.1002/(ISSN)1096-8628
|
| [23] |
Williams J, Spurlock G, Mcguffin P, et al. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group[J]. Lancet, 1996, 347(911): 1294-6.
|
| [24] |
Williams J, Mcguffin P, Nöthen M, et al. Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia[J]. Lancet, 1997, 349(960): 1221.
|
| [25] |
Bunzel R, Blümcke I, Cichon S, et al. Polymorphic imprinting of the serotonin-2A (5-HT2A) receptor gene in human adult brain[J]. Brain Res Mol Brain Res, 1998, 59(1): 90-2. doi: 10.1016/S0169-328X(98)00146-6
|
| [26] |
Kato MV, Ikawa Y, Hayashizaki Y, et al. Paternal imprinting of mouse serotonin receptor 2A gene Htr2 in embryonic eye: a conserved imprinting regulation on the RB/Rb locus[J]. Genomics, 1998, 47(1): 146-8. doi: 10.1006/geno.1997.5089
|
| [27] |
Turecki G, Brière R, Dewar K, et al. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide[J]. Am J Psychiatry, 1999, 156(9): 1456-8. https://www.researchgate.net/publication/12815120_Prediction_of_level_of_serotonin_2A_receptor_binding_by_serotonin_receptor_2A_genetic_variation_in_postmortem_brain_samples_from_subjects_who_did_or_did_not_commit_suicide
|
| [28] |
Khait VD, Huang YY, Zalsman G, et al. Association of serotonin 5-HT2A receptor binding and the T102C polymorphism in depressed and healthy Caucasian subjects[J]. Neuropsychopharmacology, 2005, 30(1): 166-72. doi: 10.1038/sj.npp.1300578
|
| [29] |
Lu B, Martinowich K. Cell biology of BDNF and its relevance to schizophrenia[J]. Novartis Found Symp, 2008, 289: 119-29; discussion 129-35, 193-5. doi: 10.1002/SERIES1767
|
| [30] |
Roth TL, Lubin FD, Funk AJ, et al. Lasting epigenetic influence of early-life adversity on the BDNF gene[J]. Biol Psychiatry, 2009, 65(9): 760-9. doi: 10.1016/j.biopsych.2008.11.028
|
| [31] |
Mill J, Tang T, Kaminsky Z, et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis[J]. Am J Hum Genet, 2008, 82(3): 696-711. doi: 10.1016/j.ajhg.2008.01.008
|
点击查看大图
下载:
